Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Hecla Mining B Pref | HL-B | Nov 22, 2024 | 54.20 | 0.00 |
Hedge Replication ETF Proshares | HDG | Nov 22, 2024 | 50.31 | +0.10 |
Heico | HEI | Nov 22, 2024 | 279.02 | +0.60 |
Heico A | HEI-A | Nov 22, 2024 | 215.57 | +0.07 |
Heidrick & Struggles International | HSII | Nov 22, 2024 | 46.57 | -0.04 |
Helen of Troy | HELE | Nov 22, 2024 | 69.92 | +1.25 |
Helios Technologies | HLIO | Nov 22, 2024 | 53.08 | +1.47 |
Helius Medical Technologies A | HSDT | Nov 22, 2024 | 0.45 | +5.35 |
Helix Acquisition II | HLXB | Nov 22, 2024 | 10.42 | 0.00 |
Helix Energy Solutions Group | HLX | Nov 22, 2024 | 11.36 | +1.52 |
Hello ADR | MOMO | Nov 22, 2024 | 6.36 | -3.05 |
Helmerich & Payne | HP | Nov 22, 2024 | 36.06 | +4.73 |
Helport AI Limited - Ordinary Shares | HPAI | Nov 22, 2024 | 5.80 | +6.03 |
Hennessy Advisors | HNNA | Nov 22, 2024 | 10.26 | -2.19 |
Hennessy Capital Investment VI SPAC A | HCVI | Nov 22, 2024 | 10.52 | 0.00 |
Hennessy Capital Investment VI Unit | HCVIU | Nov 22, 2024 | 10.55 | -0.20 |
Henry Schein | HSIC | Nov 22, 2024 | 75.08 | +1.78 |
Hepion Pharmaceuticals | HEPA | Nov 22, 2024 | 0.66 | -3.70 |
Heramba Electric Plc | PITA | Nov 22, 2024 | 1.02 | -0.97 |
Herbalife Nutrition | HLF | Nov 22, 2024 | 8.42 | -0.94 |
Herc Holdings | HRI | Nov 22, 2024 | 222.92 | +2.37 |
Hercules Capital | HTGC | Nov 22, 2024 | 18.76 | +1.24 |
Heritage Commerce | HTBK | Nov 22, 2024 | 10.91 | +1.87 |
Heritage Financial | HFWA | Nov 22, 2024 | 26.50 | +2.75 |
Heritage Global | HGBL | Nov 22, 2024 | 1.62 | +0.62 |
Heritage Insurance | HRTG | Nov 22, 2024 | 12.39 | +0.73 |
Heron Therapeutics | HRTX | Nov 22, 2024 | 1.07 | +0.94 |
Hertz Global | HTZ | Nov 22, 2024 | 4.07 | +4.76 |
Hesai Group ADR | HSAI | Nov 22, 2024 | 4.74 | +2.82 |
Hess | HES | Nov 22, 2024 | 148.65 | +0.45 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.